Germany Over the Counter (OTC) Drugs Market By Formulation Type (Tablets, Liquids, Ointments, and Sprays), By Product Type (Cough, Cold and Flu Drugs, Analgesics, Dermatologicals, Gastrointestinal Drugs, Antiseptics, Anti-Allergy Drugs, Smoking Cession Aids, Ophthalmic Drugs, Vitamins & Minerals, Sleep Aids, Weight Loss Medicines, and Other Drugs), and By Distribution Channel (Pharmacies/Drug Stores, Supermarkets/Hypermarkets, Convenience Stores, and Others)- Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Germany Over the Counter (OTC) Drugs Market By Formulation Type (Tablets, Liquids, Ointments, and Sprays), By Product Type (Cough, Cold and Flu Drugs, Analgesics, Dermatologicals, Gastrointestinal Drugs, Antiseptics, Anti-Allergy Drugs, Smoking Cession Aids, Ophthalmic Drugs, Vitamins & Minerals, Sleep Aids, Weight Loss Medicines, and Other Drugs), and By Distribution Channel (Pharmacies/Drug Stores, Supermarkets/Hypermarkets, Convenience Stores, and Others)- Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 800 | Pages: 145 | October 2016 | Region: Germany


Germany Over the Counter (OTC) drugs market has been estimated at USD 7.35 billion in 2016 and is projected to reach USD 8.17 billion by 2021, at a CAGR of 2.15% during the forecast period from 2016 to 2021. Over the Counter (OTC) drugs can be dispensed without prescription of healthcare professionals. These drugs are safe & effective and can be bought at the pharmacies and local stores, over the counter. These drugs are occasionally used for common disease conditions (cold & flu, analgesia, cough, skin diseases, and other disease conditions). Most commonly marketing OTC drugs in Germany include Acetaminophen, Aspirin, Ibuprofen, Voltaren Gel, and Dorithricin, among others. OTC drugs are developed under OTC Monograph process or through New Drug Application (NDA) process. These drugs come with a monograph, on which the ingredients of the drug, recommended dosage and user instructions are written.

Rising import of OTC drugs, increasing self-medication, growing healthcare awareness among public, and rising health care costs are some of the factors driving the growth of OTC drugs market in Germany. In addition, increasing number of chemists & pharma dispensaries and the key benefits offered by OTC drugs such as quick availability, affordability, ease of access, & customer-empowering qualities are further stimulating the growth of OTC medicines. However, lack of proper reimbursement policies, strict regulations for the import of the medicines including OTC drugs, complications involved in taking wrong medication due to lack of knowledge, and availability of other therapies (such as homeopathy) are expected to restrain the growth of OTC drugs market in Germany.

The market is segmented based on formulation type such as tablets, liquids, ointments, sprays. Among these, tablets segment commands the major market share in Germany Over the Counter (OTC) drugs market, by formulation type in 2016. OTC drugs market is also segmented based on products type such as Cough, Cold and Flu Drugs, Analgesics, Dermatologicals, Gastrointestinal Drugs, Antiseptics, Anti-Allergy Drugs, Smoking Cession Aids, Ophthalmic Drugs, Vitamins & Minerals, Sleep Aids, Weight Loss Medicines, and Other Drugs (Ear Drops & Diuretics). Of these, Analgesics, Cough, Cold & Flu, Dermatologicals, and Gastrointestinal drugs account for the largest market share in Germany Over the Counter (OTC) drugs market, by products type in 2016.

Further, the market is segmented based on distribution channel such as Pharmacies/Drug Stores, Supermarkets/Hypermarkets, Convenience Stores, and Others (online drugstores). Among these, Pharmacies/Drug Stores segment commands the largest market share in Germany Over the Counter (OTC) drugs market, by distribution channel in 2016.

The major players in Germany Over the Counter (OTC) drugs market include Bayer AG (Germany), Johnson & Johnson (U.S.), Almirall S.A. (Spain), GlaxoSmithKline Plc (U.K.), Boehringer Ingelheim GmbH (Germany), PharmaFGP GmbH (Germany), OTC-Pharma Vertrich Gmbh (Germany), Novartis AG (Switzerland), Pfizer AG (Switzerland), and Sanofi S.A. (France).

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Formulation Type                              

                                5.1.1 Tablets      

                                5.1.2 Liquids      

                                5.1.3 Ointments               

                                5.1.4 Sprays       

                5.2 By Product Type                       

                                5.2.1 Cough, Cold and Flu Drugs

                                5.2.2 Analgesics

                                5.2.3 Dermatologicals    

                                5.2.4 Gastrointestinal Drugs

                                5.2.5 Antiseptics              

                                5.2.6 Anti-Allergy Drugs

                                5.2.7 Smoking Cessation Aids     

                                5.2.8 Ophthalmic Drugs

                                5.2.9 Vitamins and Minerals       

                                5.2.10 Sleep Aids             

                                5.2.11 Weight Loss/Diet Products            

                                5.2.12 Others (Ear Drops & Diuretics)     

                5.3 By Distribution Channel                         

                                5.3.1 Pharmacies/Drugstores     

                                5.3.2 Supermarkets/Hypermarkets         

                                5.3.3 Convenience stores            

                                5.3.4 Others (Online Drugstores)             

6. Strategic Analysis                                       

                6.1 PESTLE analysis                         

                                6.1.1 Political     

                                6.1.2 Economic 

                                6.1.3 Social         

                                6.1.4 Technological         

                                6.1.5 Legal          

                                6.1.6 Environmental       

                6.2 Porter’s Five analysis                              

                                6.2.1 Bargaining Power of Suppliers        

                                6.2.2 Bargaining Power of Consumers    

                                6.2.3 Threat of New Entrants     

                                6.2.4 Threat of Substitute Products and Services              

                                6.2.5 Competitive Rivalry within the Industry     

7. Market Leaders' Analysis                                        

                7.1 Bayer AG                     

                                7.1.1 Overview 

                                7.1.2 Product Analysis   

                                7.1.3 Strategic Evaluation and Operations            

                                7.1.4 Financial analysis  

                                7.1.5 Legal issues             

                                7.1.6 Recent Developments       

                                7.1.7 SWOT analysis       

                                7.1.8 Analyst View          

                7.2 Johnson and Johnson                            

                7.3 Almirall S.A.                                

                7.4 GlaxoSmithKline Plc                                

                7.5 Boehringer Ingelheim GmbH                              

                7.6 PharmaFGP GmbH                  

                7.7 OTC-Pharma Vertrich GmbH                               

                7.8 Novartis AG                                

                7.9 Pfizer AG                     

                7.10 Sanofi S.A.                                

8. Competitive Landscape                                           

                8.1 Market share analysis                            

                8.2 Merger and Acquisition Analysis                       

                8.3 Agreements, collaborations and Joint Ventures                         

                8.4 New Product Launches                         

9. Expert Opinions                                          

                9.1 Market Outlook                        

                9.2 Investment Opportunities                   

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
Middle East and Africa Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, N...
Latin America Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Gener...
Asia-Pacific Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Genera...
Europe Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Generation s...
North America Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems (CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Gene...
Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Generation sequenci...
Middle East and Africa Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous syste...
Latin America Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, ...
Asia-Pacific Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, a...
Europe Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, anti-ca...
North America Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, ...
Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, anti-cancer dr...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.